NCT03602950

PRP Use in Diabetic Patients Undergoing Cesarean Section

Role of Autologous Platelet-Rich Plasma Solution in Wound Healing in Diabetic Patients Undergoing Elective Cesarean Delivery

• Status: Unknown
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Minia University · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

this study will investigate the effectiveness of PRP in wound healing among diabetic patients undergoing elective cesarean sections

Detailed description

In this balanced, randomized, and controlled prospective study, 100 pregnant ladies at full term diabetic patients will be admitted to Minia University hospital. The patients will be randomly assigned into two groups. The intervention group will receive PRP at surgery, whereas the control group will receive the usual care. All patients will be evaluated at baseline, one week, two weeks, four weeks and eight week after the cesarean section.

Conditions

• Diabetes, Gestational
• Wound Complication

Interventions

Type	Name	Description
BIOLOGICAL	PRP	autologous PRP will be injected subcutaneously before skin closure at time of elective CS

Timeline

• Start date: 2018-08-01
• Primary completion: 2019-02-28
• Completion: 2019-02-28
• First posted: 2018-07-27
• Last updated: 2018-07-27

Regulatory

• FDA-regulated drug study